Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Genet Med. 2022 Mar 21;24(5):1062–1072. doi: 10.1016/j.gim.2022.01.022

Table 3.

The Total and Average Number of SNVs/Indels in the Sequenced Samples (n=10,077).

All Calls Deleterious Callsa: CADD/SIFTb/Intersection
SNVs Total Counts Novel Counts Total Counts Novel Counts
All 77 Genes Number of SNVs 10,205,546 9,997,316 462,915/360,310/190,311 426,384/346,108/176,148
SNVs/Sample 1,012.8 992.1 45.9/35.8/18.9 42.3/34.4/17.5
13 Alert Genes Number of SNVs 1,388,855 1,219,760 93,875/92,352/44,614 73,987/80,835/33,136
SNVs/Sample 137.8 121.0 9.3/9.2/4.4 7.3/8.0/3.3
INDELS Total Counts Novel Counts Total Counts Novel Counts
All 77 Genes Number of Indels 620,215 576,068 11,749/0/0 1,697/0/0
Indels/Sample 61.6 57.2 1.2/0/0 0.2/0/0
13 Alert Genes Number of Indels 69,787 56,346 5,509/0/0 0/0/0
Indels/Sample 6.9 5.6 0.6/0/0 0/0/0
a

Novel Counts are total SNV/Indel variant counts excluding those included in 133 CPIC actionable variants included in the Mayo Drug-Gene Pair Alerts plus stop gain, stop loss and frameshift variants. For this analysis, “deleterious” has been defined as having a CADD score > 2017 and/or a SIFT score < 0.05.18

b

SIFT output is limited to frameshift/non-frameshift for indels.